Quest Diagnostics Surges to 449th in Trading Volume with 1.90 Billion Turnover

On March 28, 2025, Quest Diagnostics saw a significant increase in trading volume, with a turnover of 1.90 billion, marking a 31.28% rise from the previous day. This surge placed Quest Diagnostics at the 449th position in terms of trading volume for the day. The stock price of Quest Diagnostics (DGX) rose by 0.80%.

Quest Diagnostics has demonstrated a strong earnings yield of 5.85%, surpassing the industry average of 4.32%. The company's earnings have consistently exceeded analyst estimates, indicating robust financial performance.

In the longer term, Quest Diagnostics' stock has shown impressive growth, with a 10.5% increase on a year-to-date basis, outperforming the S&P 500's 2.9% decline. Over the past 52 weeks, the stock has surged by 29.3%, reflecting investor confidence in the company's prospects.

Analysts have given Quest Diagnostics an average rating of overweight, with a mean price target of $179.73. This positive outlook is supported by the company's strong position in the diagnostic information services sector, where it provides essential lab testing services to hospitals and doctors.

Quest Diagnostics' stock opened at $165.49 on Wednesday, with a 50-day moving average price of $165.70 and a 200-day moving average price of $158.82. The current stock price stands at $167.33, reflecting the company's steady growth and investor interest.